Home » Topics » Regulatory

Regulatory
RSS

Amgen files sBLA for Enbrel for improvement of physical function in RA

Oct. 1, 2002

Two rhBMP-2-based products now cleared for marketing

Sep. 26, 2002

First nucleotide analogue for HBV approved by FDA

Sep. 25, 2002

Cozaar reduces the risk of ESRD in patients with type 2 diabetes, nephropathy and hypertension

Sep. 23, 2002

New option available for patients with hypertension and diabetic kidney disease

Sep. 20, 2002

Altocor approved for additional indication

Sep. 19, 2002

Valtrex approved for treatment of cold sores

Sep. 16, 2002

New E.U. approvals sought for Pennsaid

Sep. 16, 2002

Milnacipran phase II trial in FMS completes enrollment ahead of schedule

Sep. 13, 2002

J&J to file for two new indications for Topamax

Sep. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...